I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado
{"title":"特拉贝替丁和聚脂质体阿霉素(DLP)治疗部分铂敏感卵巢癌的预算影响","authors":"I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado","doi":"10.1007/BF03320878","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino\",\"authors\":\"I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado\",\"doi\":\"10.1007/BF03320878\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":101511,\"journal\":{\"name\":\"PharmacoEconomics Spanish Research Articles\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PharmacoEconomics Spanish Research Articles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF03320878\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03320878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino